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We examined the cytotoxicity of multi-walled carbon nanotubes (MWCNTs) and the resulting cytokine
secretion in BEAS-2B cells or normal human bronchial epithelial cells (HBEpCs) in two types of culture
media (Ham’s F12 containing 10% FBS [Ham’s F12] and serum-free growth medium [SFGM]). Cellular
uptake of MWCNT was observed by ﬂuorescent microscopy and analyzed using ﬂow cytometry.
Moreover, we evaluated whether MWCNT uptake was suppressed by 2 types of endocytosis inhibitors.
We found that BEAS-2B cells cultured in Ham’s F12 and HBEpCs cultured in SFGM showed similar biolog-
ical responses, but BEAS-2B cells cultured in SFGM did not internalize MWCNTs, and the 50% inhibitory
concentration value, i.e., the cytotoxicity, was increased by more than 10-fold. MWCNT uptake was sup-
pressed by a clathrin-mediated endocytosis inhibitor and a caveolae-mediated endocytosis inhibitor in
BEAS-2B cells cultured in Ham’s F12 and HBEpCs cultured in SFGM. In conclusion, we suggest that
BEAS-2B cells cultured in a medium containing serum should be used for the safety evaluation of
nanomaterials as a model of normal human bronchial epithelial cells. However, the culture medium com-
position may affect the proteins that are expressed on the cytoplasmic membrane, which may inﬂuence
the biological response to MWCNTs.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license. 1. Introduction
Carbon nanotubes (CNTs) are an important type of nanomateri-
al and have various applications, including those in the biomedical
ﬁeld (Endo et al., 2008; Saito et al., 2009; Usui et al., 2012). How-
ever, potential adverse effects of CNTs on human health are of
great concern, considering their increasing use in composite bio-
materials and also as innovative solutions for biomedical applica-
tions or in nanomedicine (Ajayan and Tour, 2007; Boczkowski
and Lanone, 2007; Donaldson et al., 2010; Haniu et al., 2012a).
Similar to other nanomaterials, the biological response (including
inﬂammation) and toxicity of CNTs were shown to depend on
numerous physicochemical factors, including agglomeration, dis-
persibility in solution, the presence and nature of impurities, and
chemical functionalization (Nel et al., 2006; Sayes et al., 2006; Her-
zog et al., 2007; Wick et al., 2007; Donaldson and Poland, 2009;
Shvedova et al., 2009; Kolosnjaj-Tabi et al., 2010; Nagai et al.,
2011; Haniu et al., 2012b).
1680 H. Haniu et al. / Toxicology in Vitro 27 (2013) 1679–1685We recently reported that the cell type also plays a critical role
in the biological response to CNTs (Haniu et al., 2011b). BEAS-2B
human bronchial epithelial cells, MESO-1 malignant pleural meso-
thelioma cells, and THP-1 cells differentiated to macrophage-like
cells that, when exposed to MWCNTs, showed cell growth inhibi-
tion and increased cytokine secretion. These cells had the potential
to internalize MWCNTs into the cytoplasm. Moreover, we showed
that the cellular concentration of MWCNTs correlates with cyto-
toxicity in BEAS-2B and MESO-1 cells (Haniu et al., 2011a).
BEAS-2B is the most popular cell line for the evaluation of the
respiratory safety of nanomaterials (Herzog et al., 2007; Park
et al., 2008; Eom and Choi, 2009), and it is used in the safety assess-
ment of CNTs (Lindberg et al., 2009; Hirano et al., 2010; He et al.,
2011; Tsukahara and Haniu, 2011; Wang et al., 2011). However,
even when the different types of CNTs studied are accounted for,
the concentrations of CNTs that show cytotoxicity vary greatly.
This variability may be caused by the cell culture medium, because
cytotoxicity at low CNT concentrations was observed when the
cells were cultured in a medium containing serum, whereas cyto-
toxicity was only observed at very high CNT concentrations when
serum was not present in the medium.
In this study, we determined the inﬂuence of serum on the cel-
lular responses to MWCNTs and compared the biological response
between BEAS-2B cells and HBEpCs. Moreover, we conﬁrmed the
effect of endocytosis of MWCNTs.2. Materials and methods
2.1. Carbon nanotubes
MWCNTs manufactured by a chemical vapor deposition method
were provided by Hodogaya Chemical (MWNT-7; Tokyo, Japan).
The properties of these MWCNTs were obtained from Hodogaya
Chemicals (Table 1). Autoclave sterilization conditions were
121 C for 15 min. MWNT-7 was dispersed with 0.1% gelatin (Nip-
pi, Tokyo, Japan) in phosphate-buffered saline (PBS) and sonicated
for 30 min by using a water-bath sonicator.2.2. Cell culture
The BEAS-2B human bronchial epithelial cell line was pur-
chased from American Type Culture Collection (Manassas, VA,
USA). Normal HBEpCs were purchased from Cell Application (San
Diego, CA, USA). BEAS-2B cells were cultured in Ham’s nutrient
mixture F-12 (Nacalai, Tokyo, Japan) with 10% fetal bovine serum
(Ham’s F12) and passaged twice a week, or cultured in bronchial/
tracheal epithelial cell serum-free growth medium kit with
0.1 lg/ml retinoic acid (SFGM; Cell Application) and passaged
every 4 days in SFGM, with the medium exchanged every other
day. HBEpCs were cultured in SFGM and passaged every 4 days,
with the medium exchanged every other day. HBEpCs were used
by passage 4. For each study, the cells were seeded at a density
of 2  105 cells/cm2 and allowed to adhere for 24 h.Table 1
Basic properties of MWNT-7.
Average primary particle diameter size Diameter (nm) 60
Length (lm) 10
Purity >99.5%
Speciﬁc surface area (m2/g) 25–30
Real density (g/cm3) 0.005–0.012.3. Alamar blue (AB) assay
To determine the viability of cells exposed to MWNT-7, we per-
formed an AB assay (Invitrogen, Carlsbad, CA, USA) according to
the manufacturer’s instructions. The cells were incubated for
24 h at 37 C in 0.1 ml of culture medium with various concentra-
tions of MWNT-7 in 96-well culture plates. The control cells were
cultured in the culture medium containing dispersant. Viable cells
metabolized the dye, which resulted in an increase in the ﬂuores-
cence intensity, as determined by excitation/emission at 550/
600 nm on a ﬂuorescence multiplate reader (PowerScan 4, DS
Pharma Biomedical, Osaka, Japan). Cytotoxic activity was calcu-
lated as follows: percent cytotoxicity = 100  experimental value/
control value. Test media were assayed 6 times.
To determine the effect of endocytosis inhibitors, cells cultured
on 96-well culture plates for 24 h were pretreated with chlorprom-
azine hydrochloride (20 lM; Nacalai) dissolved in PBS or indo-
methacin (50 lM; SIGMA, St. Louis, MO, USA) dissolved in
ethanol for 15 min. The cells were then exposed to MWNT-7
(50 lg/ml) with the inhibitors for 2 h. The cells were washed twice
with Dulbecco’s PBS (DPBS) at 4 C and cultured in each medium
without MWNT-7 or the inhibitors for 22 h. Thereafter, the cells
treated with the AB reagent were assayed.2.4. Assessment of MWNT-7 uptake by ﬂuorescence microscopy
Cells were cultured on ibiTreat dishes (l-dish35 mm high; ibidi
GmbH, Martinsried, Germany) for 24 h in a 5% CO2 incubator.
The cells were then incubated with or without MWNT-7 (1 lg/
ml) for 24 h. Prior to observation, the cells were washed twice
and stained with bisbenzimide H33342 ﬂuorochrome trihydro-
chloride (H33342, 1 lg/ml; Nacalai) for 30 min. The cells were
visualized using differential interference contrast (DIC) and ﬂuo-
rescence by ﬂuorescence microscopy (AxioObserverZ1, Zeiss, Jena,
Germany) in a 5% CO2 chamber at 37 C using a 40 objective.
To determine the effect of endocytosis inhibitors, cells cultured
on ibiTreat dishes for 24 h were pretreated with 2 types of endocy-
tosis inhibitors for 15 min and then exposed to MWNT-7 (10 lg/
ml) and H33342 for 2 h. The cells were washed twice with DPBS
at 4 C and observed in each medium without MWNT-7 or the
inhibitors.2.5. Cytokine measurement
We previously have reported that certain cytokines as secreted
as part of the inﬂammatory response in BEAS-2B cells exposed to
MWCNTs (Tsukahara and Haniu, 2011). Although the secretion of
interleukin (IL)-6 and IL-8 was shown to increase upon exposure
to MWCNTs, other cytokines (IL-12, TNF-a, IL-10, and IL-1b) were
not detected. Therefore, we selected IL-6 and IL-8 for evaluation
in this study. Cytokines in the culture supernatant were measured
using a cytometric bead array ﬂex set system (BD Biosciences, San
Jose, CA, USA), according to the manufacturer’s protocol. Brieﬂy,
cells in a 12-well plate were exposed to various concentrations
of MWNT-7 for 24 h; subsequently, cytokine capture beads for
IL-6 and IL-8 were added to the samples, or cytokine standards
(10–5000 pg/ml) were prepared in ﬂow cytometry (FCM) tubes.
The mixtures were vortexed, and antibodies for ﬂuorescence detec-
tion were added to each tube. The samples were then incubated at
room temperature for 2 h. Following incubation, the beads were
washed once and resuspended prior to reading by a FACS Calibur™
apparatus (BD Biosciences). Test media were assayed in triplicate
for each treatment condition. The limits of detection in this kit
were lower than 1.6 pg/ml (IL-6) and 1.2 pg/ml (IL-8).
Fig. 2. Cytotoxicity of MWNT-7 in BEAS-2B cells that were cultured in different
media. BEAS-2B cells were passaged in SFGM and Ham’s F12. In the experiment,
trypsinized cells were separated into 2 groups that were cultured in the same
medium or a different medium and allowed to adhere for 24 h. The cells were
exposed to varying concentrations of MWNT-7 or dispersant for 24 h. The
cytotoxicity is indicated as a percentage of the control, and the data were
statistically compared to the data for each control (mean ± SE, n = 6, p < 0.05,
p < 0.001).
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MWNT-7 uptake was determined by FCM using our previous
methods with slight modiﬁcations (Haniu et al., 2011a). Brieﬂy,
the cells were grown on 12-well plates for 24 h and were incubated
for 2 h at 37 C in the presence or absence of MWNT-7 (50 lg/ml).
For the endocytosis inhibitor tests, the inhibitors were pre-treated
for 15 min prior to MWNT-7 exposure. The cells were washed with
DPBS at 4 C, harvested with trypsin, and centrifuged. The precipi-
tated cells were suspended in DPBS containing 10% FBS and ﬁltered
through a nylon mesh (67-lm pore size). Side scatter (SSC) in more
than 8000 events was immediately measured by light-scattering
analysis using an FACS Calibur™ apparatus. The SSC relative ratio
was calculated as follows: SSC relative ratio = SSC value of the cells
in the presence of MWNT-7/SSC value of the cells in the absence of
MWNT-7. The suspended cells were assayed in triplicate for each
treatment condition.
2.7. Statistical analysis
Data are presented as the mean ± standard error (SE). Student’s
t-test was used for data analysis, and p < 0.05 was deﬁned as statis-
tically signiﬁcant.3. Results
3.1. Cytotoxicity
We compared the cytotoxicity of MWNT-7 under the same con-
ditions in HBEpCs, which are normal human bronchial epithelial
cells, and BEAS-2B cells, which are immortalized normal human
bronchial epithelial cells (Fig. 1). Although the cell growth of
HBEpCs was suppressed by approximately 50% at an MWNT-7 con-
centration of 10 lg/ml, the growth of BEAS-2B cells was sup-
pressed by less than 30%, even at an MWNT-7 concentration of
50 lg/ml.
Therefore, we evaluated the effect of different culture media on
BEAS-2B cells. The cytotoxicity of MWNT-7 in BEAS-2B cells in dif-
ferent media determined using the AB assay is shown in Fig. 2. The
viability of BEAS-2B cells incubated in Ham’s F-12 during the assay
signiﬁcantly decreased upon treatment with 1 lg/ml MWNT-7,
regardless of the culture medium used during passage. However,
BEAS-2B cells that were incubated in SFGM during exposure toFig. 1. Cytotoxicity of MWNT-7 in BEAS-2B cells and HBEpCs cultured in SFGM.
Cells were exposed to varying concentrations of MWNT-7 or dispersant for 24 h.
The cytotoxicity is indicated as a percentage of the control, and the data were
statistically compared to the data for each control (mean ± SE, n = 6, p < 0.01,
p < 0.001).MWNT-7 did not show growth inhibition upon exposure to 1 lg/
ml MWNT-7; they only showed inhibition of cell growth without
accompanying cell death, even upon exposure to 50 lg/ml
MWNT-7 and even when they were cultured in Ham’s F12 during
passage. Because the doubling time of BEAS-2B cells is approxi-
mately 26 h and the exposure time of MWNT-7 was 24 h, we spec-
ulate that BEAS-2B cells that were exposed to 50 lg/ml MWNT-7 in
Ham’s F12 and showed less than 50% viability underwent growth
suppression but not cell death.
Images of BEAS-2B cells and HBEpCs exposed to MWNT-7 are
shown in Fig. 3. MWNT-7 was observed near the nuclei and cyto-
plasm in BEAS-2B cells in Ham’s F12 and HBEpCs in SFGM. How-
ever, BEAS-2B cells in SFGM showed low internalization of
MWNT-7, and some MWNT-7 adhered to the cell surface.3.2. Cytokine secretion
We evaluated cytokine secretion by BEAS-2B cells incubated in
Ham’s F12 and SFGM as well as HBEpCs incubated in SFGM in re-
sponse to MWNT-7. Although IL-6 secretion by untreated BEAS-
2B cells in Ham’s F12 and untreated HBEpCs was sufﬁcient for
detection (33.8 ± 5.0 and 5.1 ± 0.5 pg/ml, respectively), secretion
of IL-6 by BEAS-2B cells in SFGM was not detected (under 1.6 pg/
ml). Exposure to MWNT-7 increased IL-6 secretion by BEAS-2B
cells in Ham’s F12 and HBEpCs (Fig. 4a). However, the degree of
the increase and the MWNT-7 concentration that stimulated the
maximal increase were different: BEAS-2B cells in Ham’s F12 and
HBEpCs showed a 20-fold and 2-fold upregulation in response to
10 lg/ml and 1 lg/ml MWNT-7, respectively. Moreover, IL-6 secre-
tion in response to 50 lg/ml MWNT-7 was the same as that in re-
sponse to 10 lg/ml MWNT-7 in BEAS-2B cells in Ham’s F12, but
decreased to the level of the control in HBEpCs. IL-6 secretion by
BEAS-2B cells in SFGM was lower than the detectable limit when
the cells were exposed to MWNT-7, even at the maximum concen-
tration. IL-8 was secreted by both cell types under the untreated
condition, and the concentration was on the order of HBEpC > -
BEAS-2B in SFGM > BEAS-2B in Ham’s F12 (814.1 ± 78.9,
260.2 ± 18.6 and 169.3 ± 22.0, respectively), (Fig. 4b). Upon expo-
sure to 10 lg/ml MWNT-7, BEAS-2B cells in SFGM did not demon-
strate a change in secretion, whereas other cell conditions
produced increased IL-8 secretion. However, secretion in response
to 50 lg/ml MWNT-7 did not show a further increase. The increase
Fig. 3. Imaging of MWNT-7 uptake in BEAS-2B cells and HBEpCs. BEAS-2B cells and HBEpCs were exposed to 1 lg/ml MWNT-7 or dispersant for 24 h. DIC and ﬂuorescence
images were merged. Nuclei were stained blue by H33342.
Fig. 4. Cytokine secretion by BEAS-2B cells and HBEpCs in SFGM or Ham’s F12 in
response to MWNT-7. Cells were exposed to varying concentrations of MWNT-7 or
dispersant for 24 h. Secretion of IL-6 (a) and IL-8 (b) was compared to that in each
control (mean ± SE, n = 3, p < 0.05, p < 0.01, p < 0.001). N.D. = not detected.
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HBEpCs.3.3. Inhibition of endocytosis
Internalization of MWNT-7 by BEAS-2B cells in Ham’s F12 and
HBEpCs in SFGM was suppressed by chlorpromazine, which is aclathrin-mediated endocytosis inhibitor, and indomethacin, which
is a caveolae-mediated endocytosis inhibitor. The cells showed
extensive internalization of MWNT-7 for 2 h without the inhibi-
tors, whereas cells pre-treated with the inhibitors showed little
internalization of MWNT-7 and some MWNT-7 on the plasma
membrane, as determined using ﬂuorescence microscopy
(Fig. 5a). The amount of internalized MWNT-7 was determined
using the SSC relative ratio in BEAS-2B cells in Ham’s F12 and
HBEpCs in SFGM treated with or without the inhibitors after expo-
sure to MWNT-7 for 2 h, as shown in Fig. 5b and c. The SSC relative
ratio for BEAS-2B cells that internalized MWNT-7 in SFGM is also
shown in Fig. 5b. The amount of MWNTs internalized by BEAS-
2B cells was signiﬁcantly lower in SFGM medium than in F12
(Fig. 5b). HBEpCs exposed to MWNT-7 in SFGM internalized them
to the same extent as BEAS-2B cells exposed to MWNT-7 in Ham’s
F12 (Fig. 5b and c). Signiﬁcant 21.6% and 31.8% reductions of inter-
nalization were observed in the presence of chlorpromazine in
BEAS-2B cells in Ham’s F12 and HBEpCs in SFGM, respectively,
and 50.1% and 28.0% reductions were observed in the presence of
indomethacin. Moreover, we assayed cell growth inhibition by
using the AB assay to conﬁrm the inﬂuence of the endocytosis
inhibitors. Both endocytosis inhibitors suppressed the cell growth
inhibition mediated by MWNT-7 in BEAS-2B cells in Ham’s F12
and HBEpCs in SFGM (Fig. 5d). Chlorpromazine suppressed
MWNT-7 internalization and cell growth inhibition to a higher de-
gree than did indomethacin in BEAS-2B cells in Ham’s F12, and the
reverse pattern was observed for HBEpC in SFGM.4. Discussions
BEAS-2B cells were originally established by infection of normal
human bronchial epithelial cells with an adenovirus 12-SV40 hy-
brid virus (Reddel et al., 1988). Ke et al. reported that in BEAS-2B
cells, most cells at clonal density undergo squamous differentiation
when incubated in media containing more than 4% serum (Ke et al.,
1988). In this study, BEAS-2B cells in Ham’s F12 internalized
MWNT-7 and demonstrated a 50% inhibitory concentration that
was approximately 10-fold lower than that of BEAS-2B in SFGM,
as shown in Fig. 2. This result supports our hypothesis that the cul-
ture medium affects cytotoxicity in BEAS-2B cells. Cellular uptake
of MWNT-7 by differentiated BEAS-2B cells observed in the pres-
ence of fetal bovine serum was lost when the MWNT-7 treatment
Fig. 5. Effect of endocytosis inhibitors on biological responses to MWNT-7 in BEAS-2B cells and HBEpCs. (a) BEAS-2B cells in Ham’s F12 and HBEpCs were pre-treated with or
without chlorpromazine (clathrin-mediated endocytosis inhibitor) or indomethacin (caveolae-mediated endocytosis inhibitor) for 15 min and exposed to 10 lg/ml MWNT-7
or dispersant for 2 h. The cells were washed, and the nuclei were stained blue by H33342. DIC and ﬂuorescence images were merged. (b) BEAS-2B cells in Ham’s F12 were pre-
treated with or without chlorpromazine for 15 min and exposed to 50 lg/ml MWNT-7 or dispersant for 2 h. BEAS-2B cells in SFGM were exposed to 50 lg/ml MWNT-7 or
dispersant for 2 h. The cells were suspended in F-DPBS, and the SSC value was measured using a ﬂow cytometer. The SSC relative ratio was compared to that in BEAS-2B cells
exposed to MWNT-7 in Ham’s F12 (mean ± SE, n = 3, p < 0.01, p < 0.001). (c) HBEpCs in SFGM were pre-treated with or without indomethacin for 15 min and exposed to
50 lg/ml MWNT-7 or dispersant for 2 h. The cells were suspended in F-DPBS, and the SSC value was measured using a ﬂow cytometer. The SSC relative ratio was compared to
that of HBEpCs exposed to MWNT-7 (mean ± SE, n = 3, p < 0.05, p < 0.01). (d) BEAS-2B cells in Ham’s F12 and HBEpCs were pre-treated with or without chlorpromazine or
indomethacin for 15 min and exposed to 50 lg/ml MWNT-7 or dispersant for 2 h. Subsequently, the cells were subjected to AB assay after washing and culture for an
additional 22 h. The cytotoxicity is presented as a percentage of the control, and the data were statistically compared to the data for cells exposed to MWNT-7 without the
inhibitors (mean ± SE, n = 6, p < 0.01, p < 0.001).
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2B cells is not an original property and is induced by FBS (Fig. 2).
Moreover, MWNT-7 was again internalized when BEAS-2B cells
that had been cultured in SFGM and had thus lost their capacity
for MWNT-7 uptake were again cultured in Ham’s F12. Normal
HBEpCs in SFGM showed MWNT-7 internalization and growthinhibition identical to the observations in BEAS-2B cells in Ham’s
F12 (Figs. 1 and 3). We also used another line of HBEpCs purchased
from a different company and obtained the same result (data not
shown). These cells had an ellipsoid phenotype, although the
HBEpCs appeared to be cuboidal, and BEAS-2B cells in Ham’s F12
were squamous. In contrast, BEAS-2B cells in SFGM displayed a
1684 H. Haniu et al. / Toxicology in Vitro 27 (2013) 1679–1685spindle shape that is typically observed when normal human bron-
chial epithelial cells differentiate (Zhang et al., 2011). These results
cannot be attributed to the increased solubility of CNTs in serum;
rather, they are based on functional changes with resulting mor-
phological changes that occur in the presence of serum (Fig. 3).
Cytokine secretion also showed a similar pattern in response to
CNT internalization. BEAS-2B cells in Ham’s F12 and HBEpC
showed increased secretion of IL-6 and IL-8 upon exposure to
CNTs, although there was a large difference in IL-6 secretion be-
tween cell types. We did not detect secretion of IL-6 in untreated
BEAS-2B cells in SFGM (Fig. 4a). IL-8 secretion was not increased
by exposure of BEAS-2B cells in SFGM to MWNT-7, although
BEAS-2B cells in both types of culture medium secreted the same
amount of IL-8 without MWNT-7 exposure (Fig. 4b). In the
1990s, it was reported that BEAS-2B cells cultured in SFCM pro-
duced cytokines, including IL-6 and IL-8, when stimulated by bio-
active substances such as tumor necrosis factor a or histamine
(Nakamura et al., 1991; Noah et al., 1991; Levine et al., 1993).
BEAS-2B cells used for the safety evaluation of nanomaterials are
cultured in a medium in which serum is present or absent. Some
previous studies detected IL-6 or IL-8 secretion by untreated
BEAS-2B cells cultured in a medium containing serum, and showed
that such secretion was increased by nanomaterials (Hirano et al.,
2010; Heng et al., 2011; Zhao et al., 2012). However, few research-
ers have assayed the cytokines secreted by BEAS-2B cells exposed
to nanomaterials in SFCM (Ovrevik et al., 2009). Our ﬁndings of
growth inhibition and cytokine secretion, in conjunction with the
previous studies described above, indicate that the biological re-
sponse to nanomaterials in BEAS-2B cells varies depending on
the bioactive substances present, and BEAS-2B cells cultured in a
medium containing serum seem to better reﬂect the biological re-
sponse of normal human bronchial cells than BEAS-2B cells cul-
tured in a serum-free medium. Moreover, it is suggested that
internalization of MWNT-7 is important for the induction of IL-6
and IL-8 secretion.
We previously reported that CNT internalization was sup-
pressed by cytochalasin D, which is an endocytosis inhibitor, in 3
types of cells (Haniu et al., 2011b). In this study, we used 2 types
of endocytosis inhibitors. One was chlorpromazine, which is a
clathrin-mediated endocytosis inhibitor, and the other was indo-
methacin, which is a caveolae-mediated endocytosis inhibitor
(Yumoto et al., 2012). CNT internalization was suppressed by both
types of endocytosis inhibitors (Fig. 5a–d). Kostarelos et al. (2007)
reported that the cellular uptake of functionalized carbon nano-
tubes is independent of cell type and not inhibited by sodium
azide, which is an endocytosis inhibitor. However, our present
study and previous ﬁndings indicate that cellular uptake changes
in response to cell differentiation and is inhibited by endocytosis
inhibitors (Haniu et al., 2011b). The MWCNTs that we used in this
study were not functionalized or labeled with ﬂuorescein isothio-
cyanate. The mechanism of MWCNT uptake may depend on
whether the MWCNT is modiﬁed (Tabet et al., 2011). Additionally,
the recognition mechanism may vary depending on the proteins
expressed on the cytoplasmic membrane (Shi et al., 2011; Vácha
et al., 2011). Further study is necessary to identify the proteins
on the cytoplasmic membrane that are affected by the medium
composition to explain the exact mechanism of endocytosis.
In conclusion, we found that the differentiation of the cells af-
fected MWCNT uptake and the biological responses to MWCNTs
in BEAS-2B cells cultured in a medium containing serum or not.
Furthermore, we found that BEAS-2B cells cultured in a medium
containing serum show biological responses that are very similar
to those of normal human bronchial epithelial cells, as determined
by comparison with HBEpCs. These results reveal the importance
of appropriate usage of cell lines and culture conditions when per-
forming safety assessment of nanomaterials for humans in vitro. Itis necessary to determine not only the pharmacokinetics of the
nanomaterial but also the mechanism of its cellular internalization.
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